JAMA Otolaryngology
banner
jamaotolaryngology.com
JAMA Otolaryngology
@jamaotolaryngology.com
JAMA Otolaryngology–Head & Neck Surgery is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

🌐 JAMAOtolaryngology.com
Poor olfaction in older adults is linked to increased coronary heart disease risk, especially in the initial years after assessment.

ja.ma/4pCr07r
January 17, 2026 at 3:00 PM
In patients with advanced olfactory neuroblastoma, IMRT and PBRT yielded similar long-term outcomes and rates of grade 2 or higher radiation-related adverse events.

ja.ma/4aYiaxj
January 17, 2026 at 12:00 PM
A new 4-stage audiometric system using pure tone average and word recognition score enables personalized #CochlearImplant candidacy estimates, supporting more individualized patient-clinician counseling. ja.ma/4pyPf6t
January 15, 2026 at 4:30 PM
Among Medicare patients undergoing balloon sinus dilation, 60% received dilation of all 6 sinuses, despite consensus that fewer sinuses usually require intervention. ja.ma/4qUiQse
January 15, 2026 at 12:00 PM
Artificial neural networks trained on routine clinical data reliably stratified older adults with head and neck squamous cell carcinoma into high- and low-risk groups for overall and progression-free survival.

ja.ma/4sFMV0m
January 14, 2026 at 12:00 PM
Among US adults, women had up to 44% higher odds of chronic rhinosinusitis without polyps and 37% lower odds of the polyp-associated form compared to men. ja.ma/4aZ2JoJ
January 11, 2026 at 12:00 PM
Early palliative care for head and neck cancer may provide more cost-efficient end-of-life care but not facilitate home deaths, for which a coordinated team-based approach may be required. ja.ma/45NCqOD
January 10, 2026 at 5:00 PM
#AI-based imaging classification of extranodal extension in HPV-positive oropharyngeal carcinoma predicted worse outcomes and surpassed radiologist accuracy. ja.ma/49O3IH1
January 10, 2026 at 12:00 PM
A rapid 5-item mobile app olfactory test had 74% sensitivity and 86% specificity for olfactory dysfunction, supporting its use as a reliable, scalable screening tool for adults. ja.ma/49sqPp9
January 9, 2026 at 3:00 PM
In adults receiving #cochlear implants, gains in positive affect and reductions in negative affect corresponded with improvements in quality-of-life scores across listening, communication, and participation domains. ja.ma/49rqFyj
January 8, 2026 at 4:30 PM
In this podcast, Paul Bryson, MD, MBA, speaks with Yael Bensoussan, MD, MSc, and Victoria Sanchez, AuD, PhD about why hearing health is a critical and overlooked component in voice biomarker research.

🎧 Listen now: ja.ma/3LraJnU
January 5, 2026 at 3:00 PM
Early palliative care for head and neck cancer may provide more cost-efficient end-of-life care but not facilitate home deaths, for which a coordinated team-based approach may be required.

ja.ma/4pmiERq
January 5, 2026 at 12:00 PM
A 31-year-old female presented with a progressively enlarging left submandibular mass and history of pleomorphic adenoma of the left submandibular gland.

What is your diagnosis? ja.ma/4q7hPx3
January 4, 2026 at 4:00 PM
Individualized prognostic counseling using an online model was linked to reduced decisional conflict and regret and more active decision-making in #HNSCC patients.

ja.ma/4pr1rq3
January 3, 2026 at 3:00 PM
Strategic sponsor decisions and poor accrual are the leading reasons for early termination of #HNSCC clinical trials, especially in industry-funded and phase 1 studies. ja.ma/3N0G7tZ
January 2, 2026 at 4:30 PM
Fourteen cancer-testis antigens were validated as tumor-specific immunotherapy targets in head and neck squamous cell carcinoma. ja.ma/3L9ktmK
January 1, 2026 at 3:00 PM
Deep transfer learning using presurgical brain MRI features predicted post–cochlear implant language improvement in children with >92% accuracy, outperforming traditional ML. ja.ma/4azapxG
December 27, 2025 at 3:00 PM
Medicare reimbursement for #ThyroidSurgery decreased 38.7% between 2000 and 2023, with total #thyroidectomy reimbursement falling nearly 48% after adjusting for inflation. ja.ma/4qrNN6H
December 27, 2025 at 1:00 PM
Systematic review and meta-analysis: Active surveillance for low-risk papillary thyroid microcarcinoma was consistently associated with equal or better health-related quality of life compared with surgery across multiple thyroid-specific domains. ja.ma/4qt0q1G
December 26, 2025 at 4:30 PM
Fourteen cancer-testis antigens were validated as tumor-specific immunotherapy targets in head and neck squamous cell carcinoma. ja.ma/4qjgaEc
December 26, 2025 at 1:00 PM
💬 Viewpoint: Recent evidence shows that routine contralateral tonsillectomy in p16-positive tonsillar OPSCC offers minimal oncologic benefit and increases morbidity, suggesting practice change may be warranted.

ja.ma/493tIwE
December 25, 2025 at 1:00 PM
The numbers are in.

This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025, and did other readers agree?

🔗 ja.ma/4pZhcWm
December 25, 2025 at 12:00 PM
Patients with head and neck cancer and a greater number of barriers were less likely to initiate timely postoperative radiation therapy, as were those with a perioperative adverse effects–related barrier. ja.ma/4p64hAn
December 24, 2025 at 1:00 PM
The numbers are in.

The numbers are in. This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025 -- and did other readers agree?

🔗 ja.ma/497aSVw
December 23, 2025 at 4:30 PM
Early palliative care for head and neck cancer may provide more cost-efficient end-of-life care but not facilitate home deaths, for which a coordinated team-based approach may be required. ja.ma/4qr99Bt
December 23, 2025 at 1:00 PM